28. Systemic amyloidosis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 267 / Drugs : 241 - (DrugBank : 77) / Drug target genes : 68 - Drug target pathways : 180
| Other names | AL amyloidosis; | ||
|---|---|---|---|
| Disease group | Metabolic diseases | ||
| Related info (in Japanese) | - | ||
| Clinical research form [April 1, 2025 ~] (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) 028-01, 028-02, 028-03, 028-04 | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 2-5-25. Amyloid nephropathy | ||
| Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 28-1. | Immunoglobulin light chain amyloidosis;Amyloid light-chain amyloidosis;Immunoglobulin-related amyloidosis;AL amyloidosis;Reactive AA amyloidosis;Senile transthyretin amyloidosis;Senile TTR amyloidosis;Senile systemic amyloidosis; | ||
| 28-2. | Familial amyloidosis;Familial amyloid polyneuropathy;FAP; | ||